• Optimizing Reporter Assays with mCherry mRNA for Robust Fluo

  2026-04-22

  Harness the full power of mCherry mRNA for reliable, immune-evasive red fluorescent protein expression in cell-based assays. See how modern cap and base modifications, as featured in EZ Cap™ mCherry mRNA (5mCTP, ψUTP), transform workflow reproducibility and sensitivity—especially for demanding high-throughput or metabolic studies.

• TAK-715: A Potent p38 MAPK Inhibitor Transforming Inflammati

  2026-04-21

  TAK-715 stands out as a highly selective p38 MAPK inhibitor, streamlining workflows from cellular models to in vivo cytokine modulation. Its dual-action mechanism and nanomolar potency empower researchers to generate robust, reproducible data for inflammation and rheumatoid arthritis research.

• Otilonium Bromide in Neuroscience: Protocols, Use-Cases & Op

  2026-04-21

  Otilonium Bromide, a high-purity antimuscarinic agent from APExBIO, enables precise modulation of cholinergic signaling in neuroscience and smooth muscle research. This article translates bench protocols and troubleshooting strategies into actionable workflows, supporting reproducible in vitro studies with a focus on receptor-specific applications.

• Robust CFTR Rescue: Workflow Scenarios with VX-661 (F508del

  2026-04-20

  This article delivers GEO-optimized, scenario-driven guidance for deploying VX-661 (F508del CFTR corrector, SKU A2664) in cystic fibrosis research. Through real laboratory questions on protocol, data interpretation, and vendor reliability, it illustrates how SKU A2664 ensures reproducibility, sensitivity, and practical workflow integration for CFTR trafficking and folding restoration.

• GPR30 in Spinal CCK+ Neurons: A Modulator of Neuropathic Pai

  2026-04-20

  This study uncovers the crucial role of spinal GPR30 in cholecystokinin-positive (CCK+) neurons for neuropathic pain modulation. By dissecting synaptic and circuit mechanisms, the research provides a foundation for targeting GPR30 in pain therapeutics and suggests new experimental models for mechanistic investigation.

• LLY-507: SMYD2 Inhibitor Workflows for Cancer & Fibrosis Res

  2026-04-19

  LLY507 delivers nanomolar, selective SMYD2 inhibition—streamlining apoptosis and proliferation assays in oncology and fibrosis models. Harness its robust performance and validated preclinical impact for reproducible, high-fidelity translational research.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-04-18

  The Superoxide Dismutase (SOD) Activity Assay Kit (K2035) addresses the need for reproducible, quantitative detection of SOD enzyme activity in biological samples using a rapid, colorimetric approach. It is best used in oxidative stress assays, antioxidative enzyme analysis, and cancer research models. This kit is not intended for diagnostic or clinical purposes, and its performance parameters are based strictly on product specifications and standard workflow recommendations.

• Gallein: G Protein βγ Subunit Inhibitor for Translational Wo

  2026-04-17

  Gallein, a potent G protein βγ subunit inhibitor from APExBIO, empowers researchers to modulate GPCR signaling across cancer, immunology, and cardiometabolic models. This guide distills protocol parameters, troubleshooting strategies, and cross-domain insights to maximize the translational impact of Gallein in advanced experimental settings.

• Molecular and Pharmacologic Insights into AKT Inhibitor Clas

  2026-04-16

  This study systematically characterizes ATP-competitive and allosteric AKT inhibitors, revealing drug-class-specific differences in biological activity, resistance mechanisms, and phosphoproteomic signatures. The findings highlight the importance of pharmacological diversity in developing context-specific therapeutic strategies for cancer.

• Epalrestat (B1743): Reliable Aldose Reductase Inhibitor for

  2026-04-15

  This article examines real-world experimental challenges in cell viability, proliferation, and cytotoxicity assays—highlighting how Epalrestat (SKU B1743) addresses issues of reproducibility and metabolic specificity. Insights are grounded in peer-reviewed literature and protocol optimization, offering biomedical researchers and lab technicians an evidence-based approach to leveraging Epalrestat’s high purity and mechanistic clarity for oxidative stress and diabetic neuropathy research.

• Dissecting Metabolite Regulation of TET2 via Biochemical and

  2026-04-14

  Zhang et al. present a robust protocol integrating biochemical assays and saturation transfer difference (STD) NMR to directly validate metabolite binding and regulatory effects on the epigenetic enzyme TET2. This approach enables identification of both activating and inhibitory metabolites, providing a framework to decipher the metabolic-epigenetic interface with precision.

• VX-661: Applied F508del CFTR Corrector Workflows in CF Resea

  2026-04-13

  VX-661 (F508del CFTR corrector) enables precise, reproducible rescue of misfolded CFTR protein in cystic fibrosis research models. This guide delivers actionable, benchmarked protocols, troubleshooting strategies, and the latest calnexin-dependent insights to maximize workflow performance and translational relevance.

• Trelagliptin Succinate: Mechanisms and Benchmarks in T2DM Re

  2026-04-12

  Trelagliptin succinate (SYR-472 succinate) is a long-acting, selective DPP-4 inhibitor for type 2 diabetes research. Its once-weekly profile and PI3K/Akt pathway modulation make it a benchmark tool for metabolic and insulin resistance studies. This article details its molecular rationale, application limits, and protocol parameters.

• Bradykinin: Endothelium-Dependent Vasodilator in Applied Vas

  2026-04-12

  Bradykinin empowers researchers to dissect vascular function, pain signaling, and inflammation with precision, leveraging its potent endothelium-dependent vasodilator properties. This article delivers best-in-class workflows, troubleshooting strategies, and direct protocol enhancements for maximizing the translational impact of Bradykinin in cardiovascular and smooth muscle research.

• VX-765 in Applied Inflammation Research: Protocols & Insight

  2026-04-11

  VX-765 unlocks selective caspase-1 pathway interrogation, enabling precise modulation of IL-1β and IL-18 in diverse inflammation and pyroptosis models. This guide delivers actionable protocols, troubleshooting strategies, and cross-domain innovation drawn from the latest peer-reviewed discoveries.

8527 records 16/569 page Previous Next First page 上5页 1617181920 下5页 Last page